Deutsche Märkte geschlossen

Laboratory Corporation of America Holdings (LH)

NYSE - Nasdaq Echtzeitpreis. Währung in USD
Zur Watchlist hinzufügen
212,01+5,37 (+2,60%)
Börsenschluss: 03:59PM EDT
212,02 +0,01 (+0,00%)
Nachbörse: 04:02PM EDT

Laboratory Corporation of America Holdings

358 South Main Street
Burlington, NC 27215
United States
336 229 1127

BrancheDiagnostics & Research

Leitende Angestellte

Mr. Adam H. SchechterPres, CEO & Chairman5,51MN/A1965
Mr. Glenn A. EisenbergCFO & Exec. VP2,3MN/A1961
Dr. Brian J. Caveney M.P.H., M.D., J.D., MPHExec. VP, Pres of Diagnostics & Chief Medical Officer1,57MN/A1974
Mr. Mark S. SchroederExec. VP and Pres of Diagnostics Laboratory Operations & Global Supply Chain1,59MN/A1961
Dr. Paul R. Kirchgraber M.D.Exec. VP & CEO of Covance Drug Devel.2,02MN/A1962
Dr. Michelle Abelson Ph.D.Laboratory Director of OperationsN/AN/AN/A
Mr. Peter J. WilkinsonSr. VP & Chief Accounting OfficerN/AN/A1972
Mr. Lance V. BerberianExec. VP and Chief Information & Technology OfficerN/AN/A1963
Dr. Marcia T. Eisenberg Ph.D.Chief Scientific Officer & Sr. VPN/AN/A1960
Chas CookVP of Investor RelationsN/AN/AN/A
Die Beträge haben den Stand 31. Dezember 2021 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in USD.


Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C and vitamin D, prostate-specific antigens, tests for sexually transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests. The company also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases, including anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, and parentage and donor testing; and occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests. It provides online and mobile applications to enable patients to check test results; and online applications for managed care organizations and accountable care organizations. It offers end-to-end drug development, medical device, and companion diagnostic development solutions from early-stage research to clinical development and commercial market access. It serves managed care organizations, pharmaceutical, biotechnology, medical device and diagnostics companies, governmental agencies, physicians and other healthcare providers, hospitals and health systems, employers, patients and consumers, contract research organizations, and independent clinical laboratories. Laboratory Corporation of America Holdings has a collaboration agreement with Tigerlily Foundation to increase clinical trial diversity for women of color. The company was incorporated in 1994 and is headquartered in Burlington, North Carolina.

Corporate Governance

Laboratory Corporation of America Holdingss ISS Governance QualityScore, Stand 1. September 2022, lautet 1. Die grundlegenden Scores sind Audit: 8, Vorstand: 7, Shareholderrechte: 1, Kompensation: 1.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.